Brief: Collegium Obtains Six Month Extension Of U.S. Pediatric Exclusivity For Nucynta Franchise
13/06/2024 13:45
June 13 (Reuters) - Collegium Pharmaceutical Inc
COLL.O :
* COLLEGIUM OBTAINS SIX MONTH EXTENSION OF U.S. PEDIATRIC
EXCLUSIVITY FOR NUCYNTA FRANCHISE
Source text for Eikon: ID:nGNX3K0yNQ
Further company coverage: COLL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%